Article
mRNA vaccine platform demonstrates potent immunotherapeutic targeting of amyloid-β and tau pathologies in Alzheimer's disease
2025-09-16
Abstract excerpt
<title>Abstract</title> <p>Current Alzheimer’s disease (AD) immunotherapeutics face efficacy and safety limitations with antibody-based approaches. While active immunization targeting Aβ and Tau pathologies represents a promising therapeutic avenue, existing peptide/protein vaccines fail to sustain adequate antibody titers or durable immune responses. mRNA vaccines offer a promising alternative, combining sustain...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 11b313e7-85e0-50bf-92b3-c7a7a39515bf
- DOI
- 10.21203/rs.3.rs-7514957/v1
